Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
64 studies found for:    Open Studies | "Vitamin K"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Vitamin K"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients
Condition: Cardiovascular Diseases
Intervention: Drug: Vitamin K1
2 Recruiting Vitamin K Supplementation in Patients on Hemodialysis
Conditions: End Stage Renal Failure on Dialysis;   Atrial Fibrillation
Intervention: Drug: vitamin K1
3 Recruiting Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Prediabetes;   Dyslipidemia;   Diabetes
Interventions: Dietary Supplement: Placebo-Control;   Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45 mcg/d);   Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
4 Recruiting Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)
Conditions: Obesity;   Insulin Resistance;   Obesity in Diabetes;   Nutritional and Metabolic Diseases;   Hyperlipidemia;   Hyperglycemia;   Cardiovascular Diseases
Interventions: Dietary Supplement: Placebo-Control;   Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45-mcg/d);   Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
5 Recruiting Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy
Conditions: Calciphylaxis;   Calcific Uremic Arteriolopathy
Interventions: Dietary Supplement: Vitamin K;   Other: Placebo
6 Recruiting Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
Condition: Endstage Kidney Disease
Interventions: Drug: Vitamin K1;   Drug: Chrystalline Lactose
7 Recruiting Bicuspid Aortic Valve Stenosis and the Effect of vItamin K2 on Calciummetabolism on 18F-NaF PET/MRI
Conditions: Aortic Valve Stenosis;   Bicuspid Aortic Valve
Interventions: Dietary Supplement: Vitamin K2;   Other: Placebo
8 Recruiting Vitamin K and Glucose Metabolism in Adults at Risk for Diabetes (Vita-K 'n' Adults Study)
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Beta-Cell Dysfunction;   Prediabetes
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Low-Dose Vitamin K2 Supplement (menaquinone-7; 90-mcg/d);   Dietary Supplement: High-Dose Vitamin K2 Supplement (menaquinone-7; 180-mcg/d)
9 Recruiting Vitamin K2 for Reduction the Calcium at Carotid Bifurcation in Patients With Subcritical Lesions
Condition: Carotid Plaques
Intervention: Other: Nutraceutical product based on vitamin K2 (PLAK2)
10 Recruiting Treatment to Reduce Vascular Calcification In Hemodialysis Patients Using Vitamin K
Conditions: Vascular Calcification;   Systemic and Arterial Stiffness;   Complication of Hemodialysis;   Deficiency of Vitamin K2
Intervention: Drug: menaquinone-7
11 Recruiting Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients
Condition: Vascular Calcification
Interventions: Drug: rivaroxaban;   Dietary Supplement: Vitamin K2
12 Recruiting Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients
Conditions: Vitamin K Supplementation;   Endstage Renal Disease;   Cardiovascular Disease;   Bone Disease
Interventions: Dietary Supplement: Vitamin K2 (MK7);   Other: Placebo
13 Not yet recruiting INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority
Condition: Rheumatic Heart Disease
Interventions: Drug: Rivaroxaban (20 mg);   Drug: Vitamin K antagonists (VKA)
14 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol
15 Recruiting Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
Condition: Atrial Fibrillation
Interventions: Drug: Vitamin K antagonist;   Drug: Apixaban
16 Recruiting Patient Convenience Study- NIS RELATE
Condition: Atrial Fibrillation
Interventions: Drug: Pradaxa (dabigatran);   Drug: Vitamin K antagonist
17 Recruiting A Randomized, Placebo-controlled, Double Blind Trial to Investigate Whether Vitamin K2 Can Influence Arterial Calcification in Patients With Type 2 Diabetes
Conditions: Arterial Calcification;   Diabetes Mellitus Type 2
Interventions: Dietary Supplement: Menaquinone-7;   Dietary Supplement: Placebo
18 Not yet recruiting Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Condition: Atrial Fibrillation
Interventions: Drug: Edoxaban;   Drug: Clopidogrel;   Drug: Prasugrel;   Drug: ticagrelor
19 Recruiting Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib 400mg twice daily + intravenous infusion ofVit K1;   Drug: Sorafenib 400 mg twice daily + Intravenousinfusion of placebo
20 Recruiting Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD
Condition: Cervical Artery Dissection
Interventions: Drug: Acetylsalicylic acid;   Drug: vitamin K-antagonist

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.